United States Pulmonary Drug Delivery Devices Market Report 2019

Table of Contents

United States Pulmonary Drug Delivery Devices Market Report 2017
1 Pulmonary Drug Delivery Devices Overview
1.1 Product Overview and Scope of Pulmonary Drug Delivery Devices
1.2 Classification of Pulmonary Drug Delivery Devices by Product Category
1.2.1 United States Pulmonary Drug Delivery Devices Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Pulmonary Drug Delivery Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Dry Powder Inhaler
1.2.4 Metered Dose Inhaler
1.2.5 Nebulizer
1.3 United States Pulmonary Drug Delivery Devices Market by Application/End Users
1.3.1 United States Pulmonary Drug Delivery Devices Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Cystic Fibrosis
1.3.5 Other
1.4 United States Pulmonary Drug Delivery Devices Market by Region
1.4.1 United States Pulmonary Drug Delivery Devices Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Pulmonary Drug Delivery Devices Status and Prospect (2012-2022)
1.4.3 Southwest Pulmonary Drug Delivery Devices Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Pulmonary Drug Delivery Devices Status and Prospect (2012-2022)
1.4.5 New England Pulmonary Drug Delivery Devices Status and Prospect (2012-2022)
1.4.6 The South Pulmonary Drug Delivery Devices Status and Prospect (2012-2022)
1.4.7 The Midwest Pulmonary Drug Delivery Devices Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pulmonary Drug Delivery Devices (2012-2022)
1.5.1 United States Pulmonary Drug Delivery Devices Sales and Growth Rate (2012-2022)
1.5.2 United States Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2022)

2 United States Pulmonary Drug Delivery Devices Market Competition by Players/Suppliers
2.1 United States Pulmonary Drug Delivery Devices Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pulmonary Drug Delivery Devices Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pulmonary Drug Delivery Devices Average Price by Players/Suppliers (2012-2017)
2.4 United States Pulmonary Drug Delivery Devices Market Competitive Situation and Trends
2.4.1 United States Pulmonary Drug Delivery Devices Market Concentration Rate
2.4.2 United States Pulmonary Drug Delivery Devices Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pulmonary Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Product Type

3 United States Pulmonary Drug Delivery Devices Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Pulmonary Drug Delivery Devices Sales and Market Share by Region (2012-2017)
3.2 United States Pulmonary Drug Delivery Devices Revenue and Market Share by Region (2012-2017)
3.3 United States Pulmonary Drug Delivery Devices Price by Region (2012-2017)

4 United States Pulmonary Drug Delivery Devices Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Pulmonary Drug Delivery Devices Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pulmonary Drug Delivery Devices Revenue and Market Share by Type (2012-2017)
4.3 United States Pulmonary Drug Delivery Devices Price by Type (2012-2017)
4.4 United States Pulmonary Drug Delivery Devices Sales Growth Rate by Type (2012-2017)

5 United States Pulmonary Drug Delivery Devices Sales (Volume) by Application (2012-2017)
5.1 United States Pulmonary Drug Delivery Devices Sales and Market Share by Application (2012-2017)
5.2 United States Pulmonary Drug Delivery Devices Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Pulmonary Drug Delivery Devices Players/Suppliers Profiles and Sales Data
6.1 Boehringer Ingelheim GmbH
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis AG
6.2.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis AG Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline
6.3.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 AstraZeneca
6.4.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 AstraZeneca Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Teva Pharmaceutical Industries
6.5.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Merck
6.6.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Merck Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 MannKind
6.7.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 MannKind Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb
6.8.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Mylan N.V
6.9.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Mylan N.V Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Omron Corp
6.10.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Omron Corp Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 F. Hoffmann-La Roche
6.12 3M Healthcare
6.13 Sunovion Pharmaceuticals
6.14 Koninklijke Philips N.V
6.15 Gerresheimer AG
6.16 Bespak
6.17 AptarGroup
6.18 SHL Group
6.19 Nypro Healthcare
6.20 Hovione
6.21 Chiesi Farmaceutici S.P.A

7 Pulmonary Drug Delivery Devices Manufacturing Cost Analysis
7.1 Pulmonary Drug Delivery Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Pulmonary Drug Delivery Devices Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pulmonary Drug Delivery Devices Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Pulmonary Drug Delivery Devices Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Pulmonary Drug Delivery Devices Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pulmonary Drug Delivery Devices Sales Volume Forecast by Type (2017-2022)
11.3 United States Pulmonary Drug Delivery Devices Sales Volume Forecast by Application (2017-2022)
11.4 United States Pulmonary Drug Delivery Devices Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Pulmonary Drug Delivery Devices
Figure United States Pulmonary Drug Delivery Devices Market Size (K Units) by Type (2012-2022)
Figure United States Pulmonary Drug Delivery Devices Sales Volume Market Share by Type (Product Category) in 2016
Figure Dry Powder Inhaler Product Picture
Figure Metered Dose Inhaler Product Picture
Figure Nebulizer Product Picture
Figure United States Pulmonary Drug Delivery Devices Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Pulmonary Drug Delivery Devices by Application in 2016
Figure Asthma Examples
Table Key Downstream Customer in Asthma
Figure COPD Examples
Table Key Downstream Customer in COPD
Figure Cystic Fibrosis Examples
Table Key Downstream Customer in Cystic Fibrosis
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Pulmonary Drug Delivery Devices Market Size (Million USD) by Region (2012-2022)
Figure The West Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2022)
Figure United States Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pulmonary Drug Delivery Devices Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Pulmonary Drug Delivery Devices Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Pulmonary Drug Delivery Devices Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pulmonary Drug Delivery Devices Sales Share by Players/Suppliers
Figure 2017 United States Pulmonary Drug Delivery Devices Sales Share by Players/Suppliers
Figure United States Pulmonary Drug Delivery Devices Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Pulmonary Drug Delivery Devices Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Pulmonary Drug Delivery Devices Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pulmonary Drug Delivery Devices Revenue Share by Players/Suppliers
Figure 2017 United States Pulmonary Drug Delivery Devices Revenue Share by Players/Suppliers
Table United States Market Pulmonary Drug Delivery Devices Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Pulmonary Drug Delivery Devices Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Pulmonary Drug Delivery Devices Market Share of Top 3 Players/Suppliers
Figure United States Pulmonary Drug Delivery Devices Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pulmonary Drug Delivery Devices Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pulmonary Drug Delivery Devices Product Category
Table United States Pulmonary Drug Delivery Devices Sales (K Units) by Region (2012-2017)
Table United States Pulmonary Drug Delivery Devices Sales Share by Region (2012-2017)
Figure United States Pulmonary Drug Delivery Devices Sales Share by Region (2012-2017)
Figure United States Pulmonary Drug Delivery Devices Sales Market Share by Region in 2016
Table United States Pulmonary Drug Delivery Devices Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Pulmonary Drug Delivery Devices Revenue Share by Region (2012-2017)
Figure United States Pulmonary Drug Delivery Devices Revenue Market Share by Region (2012-2017)
Figure United States Pulmonary Drug Delivery Devices Revenue Market Share by Region in 2016
Table United States Pulmonary Drug Delivery Devices Price (USD/Unit) by Region (2012-2017)
Table United States Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017)
Table United States Pulmonary Drug Delivery Devices Sales Share by Type (2012-2017)
Figure United States Pulmonary Drug Delivery Devices Sales Share by Type (2012-2017)
Figure United States Pulmonary Drug Delivery Devices Sales Market Share by Type in 2016
Table United States Pulmonary Drug Delivery Devices Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Pulmonary Drug Delivery Devices Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pulmonary Drug Delivery Devices by Type (2012-2017)
Figure Revenue Market Share of Pulmonary Drug Delivery Devices by Type in 2016
Table United States Pulmonary Drug Delivery Devices Price (USD/Unit) by Types (2012-2017)
Figure United States Pulmonary Drug Delivery Devices Sales Growth Rate by Type (2012-2017)
Table United States Pulmonary Drug Delivery Devices Sales (K Units) by Application (2012-2017)
Table United States Pulmonary Drug Delivery Devices Sales Market Share by Application (2012-2017)
Figure United States Pulmonary Drug Delivery Devices Sales Market Share by Application (2012-2017)
Figure United States Pulmonary Drug Delivery Devices Sales Market Share by Application in 2016
Table United States Pulmonary Drug Delivery Devices Sales Growth Rate by Application (2012-2017)
Figure United States Pulmonary Drug Delivery Devices Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017)
Figure Novartis AG Pulmonary Drug Delivery Devices Sales Market Share in United States (2012-2017)
Figure Novartis AG Pulmonary Drug Delivery Devices Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Pulmonary Drug Delivery Devices Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Pulmonary Drug Delivery Devices Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017)
Figure AstraZeneca Pulmonary Drug Delivery Devices Sales Market Share in United States (2012-2017)
Figure AstraZeneca Pulmonary Drug Delivery Devices Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017)
Figure Merck Pulmonary Drug Delivery Devices Sales Market Share in United States (2012-2017)
Figure Merck Pulmonary Drug Delivery Devices Revenue Market Share in United States (2012-2017)
Table MannKind Basic Information List
Table MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MannKind Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017)
Figure MannKind Pulmonary Drug Delivery Devices Sales Market Share in United States (2012-2017)
Figure MannKind Pulmonary Drug Delivery Devices Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Pulmonary Drug Delivery Devices Revenue Market Share in United States (2012-2017)
Table Mylan N.V Basic Information List
Table Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan N.V Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017)
Figure Mylan N.V Pulmonary Drug Delivery Devices Sales Market Share in United States (2012-2017)
Figure Mylan N.V Pulmonary Drug Delivery Devices Revenue Market Share in United States (2012-2017)
Table Omron Corp Basic Information List
Table Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Omron Corp Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017)
Figure Omron Corp Pulmonary Drug Delivery Devices Sales Market Share in United States (2012-2017)
Figure Omron Corp Pulmonary Drug Delivery Devices Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table 3M Healthcare Basic Information List
Table Sunovion Pharmaceuticals Basic Information List
Table Koninklijke Philips N.V Basic Information List
Table Gerresheimer AG Basic Information List
Table Bespak Basic Information List
Table AptarGroup Basic Information List
Table SHL Group Basic Information List
Table Nypro Healthcare Basic Information List
Table Hovione Basic Information List
Table Chiesi Farmaceutici S.P.A Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pulmonary Drug Delivery Devices
Figure Manufacturing Process Analysis of Pulmonary Drug Delivery Devices
Figure Pulmonary Drug Delivery Devices Industrial Chain Analysis
Table Raw Materials Sources of Pulmonary Drug Delivery Devices Major Players/Suppliers in 2016
Table Major Buyers of Pulmonary Drug Delivery Devices
Table Distributors/Traders List
Figure United States Pulmonary Drug Delivery Devices Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Pulmonary Drug Delivery Devices Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Pulmonary Drug Delivery Devices Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Pulmonary Drug Delivery Devices Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Pulmonary Drug Delivery Devices Sales Volume (K Units) Forecast by Type in 2022
Table United States Pulmonary Drug Delivery Devices Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Pulmonary Drug Delivery Devices Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Pulmonary Drug Delivery Devices Sales Volume (K Units) Forecast by Application in 2022
Table United States Pulmonary Drug Delivery Devices Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Pulmonary Drug Delivery Devices Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pulmonary Drug Delivery Devices Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pulmonary Drug Delivery Devices Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources